Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

<p>Abstract</p> <p>Background</p> <p>GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are working in partnership to develop a malaria vaccine to protect infants and children living in malaria endemic regions of sub-Saharan Africa, which can be deliver...

Повний опис

Бібліографічні деталі
Автори: Macete Eusebio, Abdulla Salim, Owusu-Agyei Seth, Cahill Conor, Ofori-Anyinam Opokua, Lievens Marc, Vekemans Johan, Leach Amanda, Njuguna Patricia, Savarese Barbara, Loucq Christian, Ballou W Ripley
Формат: Стаття
Мова:English
Опубліковано: BMC 2011-08-01
Серія:Malaria Journal
Онлайн доступ:http://www.malariajournal.com/content/10/1/224